LMH cells (ATCC CRL-2117) or spontaneously immortalized chicken embryonic hepatocytes (siCEH22 (link)) were grown on 0.1% gelatin-coated culture dishes in Waymouth’s media (Life Technologies, Carlsbad, CA), supplemented with 10% FBS (Life Technologies, Carlsbad, CA), and 1% penicillin–streptomycin (BioBasic, Amherst, NY) at 37 °C, in a humidified atmosphere of 5% CO2 and 95% air. At ~ 80% confluence, cells were synchronized with serum-free media overnight and treated with different doses (0, 10, and 100 nM) of recombinant human ORX-A or ORX-B (Alpha Diagnostic International, San Antonio, TX) for 24 h. The dose of orexins was selected based on pilot and previous studies16 (link),20 (link),23 (link),24 (link). 30 min before orexin treatments, LMH cells were incubated with brefeldin A (0.3 µg/mL) for 24 h and lysates and medium were subjected to immunoblot analyses. All culture experiments were performed with cells from passages 10–15 and repeated at least twice.
Free full text: Click here